| (19) |
 |
|
(11) |
EP 2 198 895 A8 |
| (12) |
CORRECTED EUROPEAN PATENT APPLICATION |
|
Note: Bibliography reflects the latest situation |
| (15) |
Correction information: |
|
Corrected version no 1 (W1 A2) |
| (48) |
Corrigendum issued on: |
|
10.11.2010 Bulletin 2010/45 |
| (43) |
Date of publication: |
|
23.06.2010 Bulletin 2010/25 |
| (22) |
Date of filing: 30.01.2009 |
|
| (51) |
International Patent Classification (IPC):
|
|
| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO
PL PT RO SE SI SK TR |
|
Designated Extension States: |
|
AL BA RS |
| (30) |
Priority: |
19.12.2008 US 318038
|
| (71) |
Applicant: Xylos Corporation |
|
Langhorner, PA 19047 (US) |
|
| (72) |
Inventors: |
|
- Serafica, Gonzalo
Newtown, Pennsylvania 18940 (US)
- Weinberger, Lauren
Philadelphia, Pennsylvania 19130 (US)
|
| (74) |
Representative: HOFFMANN EITLE |
|
Patent- und Rechtsanwälte
Arabellastrasse 4
81925 München
81925 München (DE) |
|
| |
|
| (54) |
Porous structures of microbial-derived cellulose for in vivo implantation |
(57) A transgenic plant transformed by a casein kinase Stress-Related Polypeptide (CKSRP)
coding nucleic acid, wherein expression of the nucleic acid sequence in the plant
results in increased tolerance to environmental stress as compared to a wild type
variety of the plant. Also provided are agricultural products, including seeds, produced
by the transgenic plants. Also provided are isolated CKSRPs, and isolated nucleic
acid coding CKSRPs, and vectors and host cells containing the latter.